Allison B. Reiss is a professor at the Department of Medicine and Biomedical Research Institute, NYU Grossman Long Island School of Medicine, Mineola, NY, USA. She received her M.D. from SUNY Downstate School of Medicine and completed her Internal Medicine Residency at UMDNJ Rutgers. She is certified by the American Board of Internal Medicine. She is well published in numerous medical and scientific journals and has chaired symposia at national and international conferences. She has received recognition and funding for her work from a number of organizations, including the Alzheimer’s Foundation of America, the American Heart Association, the National Institutes of Health, the Arthritis Foundation, and the Neuroscience Education and Research Foundation. She has a strong passion for community outreach and is dedicated to improving health care, especially for older populations.

Shelly Gulkarov is a student at Adelphi University working toward a Bachelor of Science degree in Biology. She is an aspiring physician with a strong background in biomedical research. She is currently a research intern at NYU Grossman Long Island School of Medicine and is involved in studying neurodegeneration in Alzheimer’s disease, traumatic brain injury, and prostate cancer patients treated with androgen-blocking drugs. She hopes that her experience in research will better develop her understanding of the role of inflammation in the pathobiology of neurocognitive disorders as she pursues a career in medicine and biomedical research.

Aaron Pinkhasov, M.D., is the Founding Chair of the Behavioral Health Department at NYU Langone Hospital—Long Island and is a Clinical Professor of Psychiatry and Medicine at NYU Grossman Long Island School of Medicine. He completed a combined Internal Medicine and Psychiatry Residency program at SUNY Downstate in Brooklyn, New York, after which he served as Chief Resident in Internal Medicine at Kings County Hospital, Brooklyn, New York. The author of multiple publications and presentations, he has received several professional honors, including the President’s Award from the Office of the President, Borough of Brooklyn, Distinguished Recognition Award for Dedication and Commitment to Psychiatric Residency Education in Geriatric Psychiatry 2002-2014 from SUNY Downstate Medical Center, and Innovative Model for Integrated Care Award from the Association of Medicine and Psychiatry in 2017. He is a Distinguished Fellow of the American Psychiatric Association, a Fellow of the Academy of Consultation and Liaison Psychiatry, and a member of the Psychosomatic Committee at the Group for Advancement of Psychiatry. His areas of research include psychopharmacology and neurocognitive disorders, as well as the role of psychiatry service in optimizing health outcomes.

Katie M. Sheehan, B.A., is a Biomedical Research Technician at NYU Grossman Long Island School of Medicine. She is a member of the Reiss lab and her work is focused on inflammation in Alzheimer’s disease and cardiovascular diseases with a particular emphasis on evaluating drugs for repurposing in the treatment of these syndromes. After completing her undergraduate studies, she obtained her B.A. in Sociomedical Sciences and Biology from the State University of New York at Geneseo. Her experience as a student researcher inspired her to gain a deeper understanding of biomedical research by joining Dr. Reiss’ laboratory.

Ankita Srivastava is a Research Associate in the Inflammation Laboratory of Dr. Allison Reiss in the Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine. She completed her Ph.D. in 2017 from CSIR-CDRI, India, working on adipose tissue insulin resistance and non-alcoholic fatty liver diseases. She joined NYU in 2018 as a post-doctoral fellow studying a Roux-en-Y gastric bypass model of bariatric surgery in mice. She joined the Reiss lab in April 2023 and, since then, has focused on designing new and effective treatments for neurocognitive disorders such as Alzheimer’s disease and those induced by hormone deprivation. Her specific interest is in determining the molecular mechanisms underlying mitochondrial dysfunction that leads to neuronal death. She is also involved in a project characterizing the role of adipose tissue-derived exosomal microRNAs in cardiovascular disease. She has authored numerous publications in high-impact, peer-reviewed journals and presented posters and oral presentations at various conferences.

Joshua De Leon is a professor at the Department of Medicine and Biomedical Research Institute, NYU Grossman Long Island School of Medicine, Mineola, NY, USA. He received his B.A. in Biology and Philosophy from Franklin and Marshall College in 1984 and his M.D. from SUNY Downstate School of Medicine in 1988. He completed a residency in internal medicine and a fellowship in clinical and molecular cardiology at the Albert Einstein College of Medicine. He is a practicing cardiologist with extensive clinical experience in managing patients with inflammatory mechanisms underlying their cardiovascular disease and patients with disordered lipid metabolism. He has been a co-investigator on an American Heart Association-funded study of inflammation in cardiovascular disease and has participated as a site investigator for multiple clinical trials addressing acute coronary syndromes, chronic CAD management, and lipid metabolism/management. He has been listed in Castle Connolly’s “Top Doctors” series for the New York metro area.

Aaron E. Katz is a professor and Chair of the Department of Urology, NYU Grossman Long Island School of Medicine, Mineola, NY, USA. He completed his M.D. studies at New York Medical College in 1986. He has been recognized as one of Castle Connolly’s America’s Top Doctors® and “Top Doctors” for the New York metro area. He has also been named one of the “Top Doctors on Long Island” by Newsday and a top doctor in New York Magazine for many years.